Vascular targeting—a new approach to the therapy of solid tumors
- 1 January 1994
- journal article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 64 (1) , 155-174
- https://doi.org/10.1016/0163-7258(94)90037-x
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Modulation of vascular cell behavior by transforming growth factors ?Molecular Reproduction and Development, 1992
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityPublished by Elsevier ,1991
- Biotechnology Update: Overview of Monoclonal Antibodies in the Diagnosis and Therapy of CancerCancer Investigation, 1991
- Antibody targeted therapy in cancer: comparison of murine and clinical studiesCancer Treatment Reviews, 1990
- Evaluation of four CD22 antibodies as ricin a chain‐containing immunotoxins for the in vivo therapy of human B‐cell leukemias and lymphomasInternational Journal of Cancer, 1988
- Localization of biotinylated monoclonal antibody in nude mice bearing subcutaneous and intraperitoneal human tumour xenograftsInternational Journal of Cancer, 1988
- Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferonsPharmacology & Therapeutics, 1985
- Variable expression of Ia antigens on the vascular endothelium of mouse skin allograftsNature, 1983